Back to Search Start Over

Persistent endotheliopathy in the pathogenesis of long COVID syndrome

Authors :
Fogarty, H.
Townsend, L.
Morrin, H.
Ahmad, A.
Comerford, C.
Karampini, E.
Englert, H.
Byrne, M.
Bergin, C.
O’Sullivan, J.M.
Martin‐Loeches, I.
Nadarajan, P.
Bannan, C.
Mallon, P.W.
Curley, G.F.
Preston, R.J.S.
Rehill, A.M.
McGonagle, D.
Ni Cheallaigh, C.
Baker, R.I.
Renné, T.
Ward, S.E.
O’Donnell, J.S.
O’Connell, N.
Ryan, K.
Kenny, D.
Fazavana, J.
Fogarty, H.
Townsend, L.
Morrin, H.
Ahmad, A.
Comerford, C.
Karampini, E.
Englert, H.
Byrne, M.
Bergin, C.
O’Sullivan, J.M.
Martin‐Loeches, I.
Nadarajan, P.
Bannan, C.
Mallon, P.W.
Curley, G.F.
Preston, R.J.S.
Rehill, A.M.
McGonagle, D.
Ni Cheallaigh, C.
Baker, R.I.
Renné, T.
Ward, S.E.
O’Donnell, J.S.
O’Connell, N.
Ryan, K.
Kenny, D.
Fazavana, J.
Source :
Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E., Englert, H., Byrne, M., Bergin, C., O’Sullivan, J.M., Martin‐Loeches, I., Nadarajan, P., Bannan, C., Mallon, P.W., Curley, G.F., Preston, R.J.S., Rehill, A.M., McGonagle, D., Ni Cheallaigh, C., Baker, R.I. <
Publication Year :
2021

Abstract

Background Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS-CoV-2 infection. The biological mechanisms underlying this “long COVID” syndrome remain unknown. However, autopsy studies have highlighted the key roles played by pulmonary endotheliopathy and microvascular immunothrombosis in acute COVID-19. Objectives To assess whether endothelial cell activation may be sustained in convalescent COVID-19 patients and contribute to long COVID pathogenesis. Patients and Methods Fifty patients were reviewed at a median of 68 days following SARS-CoV-2 infection. In addition to clinical workup, acute phase markers, endothelial cell (EC) activation and NETosis parameters and thrombin generation were assessed. Results Thrombin generation assays revealed significantly shorter lag times (p &lt; .0001, 95% CI −2.57 to −1.02 min), increased endogenous thrombin potential (p = .04, 95% CI 15–416 nM/min), and peak thrombin (p &lt; .0001, 95% CI 39–93 nM) in convalescent COVID-19 patients. These prothrombotic changes were independent of ongoing acute phase response or active NETosis. Importantly, EC biomarkers including von Willebrand factor antigen (VWF:Ag), VWF propeptide (VWFpp), and factor VIII were significantly elevated in convalescent COVID-19 compared with controls (p = .004, 95% CI 0.09–0.57 IU/ml; p = .009, 95% CI 0.06–0.5 IU/ml; p = .04, 95% CI 0.03–0.44 IU/ml, respectively). In addition, plasma soluble thrombomodulin levels were significantly elevated in convalescent COVID-19 (p = .02, 95% CI 0.01–2.7 ng/ml). Sustained endotheliopathy was more frequent in older, comorbid patients, and those requiring hospitalization. Finally, both plasma VWF:Ag and VWFpp levels correlated inversely with 6-min walk tests. Conclusions Collectively, our findings demonstrate that sustained endotheliopathy is common in convalescent COVID-19 and raise the intriguing possibility that this may contribute to long COVID p

Details

Database :
OAIster
Journal :
Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E., Englert, H., Byrne, M., Bergin, C., O’Sullivan, J.M., Martin‐Loeches, I., Nadarajan, P., Bannan, C., Mallon, P.W., Curley, G.F., Preston, R.J.S., Rehill, A.M., McGonagle, D., Ni Cheallaigh, C., Baker, R.I. <
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1276819282
Document Type :
Electronic Resource